Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Erlinge

Showing results (191-200 of 489) with videos related to

Pageof 49
Sort By:
Open Heart|October 22, 2014
Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarctionPontus Andell, Sasha Koul, Andreas Martinsson, et al.
European Heart Journal Open|November 13, 2025
Prevalence and prediction of masked uncontrolled hypertension in patients recently hospitalized for myocardial infarctionHenrik Hellqvist, David Erlinge, Bertil Lindahl, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 10, 2019
Appropriate coronary revascularization can be accomplished if myocardial perfusion is quantified by positron emission tomography prior to treatment decisionShahnaz Akil, Fredrik Hedeer, Jenny Oddstig, et al.
American Heart Journal|November 26, 2022
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndromeElmir Omerovic, Stefan James, David Erlinge, et al.
BMJ Open|April 6, 2019
Impact of ischaemic heart disease severity and age on risk of cardiovascular outcome in diabetes patients in Sweden: a nationwide observational studyTomas Jernberg, Daniel Lindholm, Lars Pål Hasvold, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 17, 2019
Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VALIDATE-SWEDEHEART substudyTania Sharma, Rebecca Rylance, Sofia Karlsson, et al.
American Heart Journal|August 4, 2024
Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stentDavid Erlinge, Jonas Andersson, Ole Fröbert, et al.
Biochemical and Biophysical Research Communications|April 17, 2025
The DNA repair factor ku80 binds and activates the adhesion receptor ELTD1/ADGRL4Stefan Amisten, Melinda Rezeli, Mario Grossi, et al.
BMC Cardiovascular Disorders|December 22, 2014
Repeated epinephrine doses during prolonged cardiopulmonary resuscitation have limited effects on myocardial blood flow: a randomized porcine studyHenrik Wagner, Michael Götberg, Bjarne Madsen Hardig, et al.
Clinical and Translational Medicine|August 15, 2015
Semi-automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studiesJohan Malm, Henrik Lindberg, David Erlinge, et al.
Pageof 49

Showing results (191-200 of 489) with videos related to

Sort By:
Pageof 49
Open Heart|October 22, 2014
Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarctionPontus Andell, Sasha Koul, Andreas Martinsson, et al.
European Heart Journal Open|November 13, 2025
Prevalence and prediction of masked uncontrolled hypertension in patients recently hospitalized for myocardial infarctionHenrik Hellqvist, David Erlinge, Bertil Lindahl, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 10, 2019
Appropriate coronary revascularization can be accomplished if myocardial perfusion is quantified by positron emission tomography prior to treatment decisionShahnaz Akil, Fredrik Hedeer, Jenny Oddstig, et al.
American Heart Journal|November 26, 2022
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndromeElmir Omerovic, Stefan James, David Erlinge, et al.
BMJ Open|April 6, 2019
Impact of ischaemic heart disease severity and age on risk of cardiovascular outcome in diabetes patients in Sweden: a nationwide observational studyTomas Jernberg, Daniel Lindholm, Lars Pål Hasvold, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 17, 2019
Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VALIDATE-SWEDEHEART substudyTania Sharma, Rebecca Rylance, Sofia Karlsson, et al.
American Heart Journal|August 4, 2024
Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stentDavid Erlinge, Jonas Andersson, Ole Fröbert, et al.
Biochemical and Biophysical Research Communications|April 17, 2025
The DNA repair factor ku80 binds and activates the adhesion receptor ELTD1/ADGRL4Stefan Amisten, Melinda Rezeli, Mario Grossi, et al.
BMC Cardiovascular Disorders|December 22, 2014
Repeated epinephrine doses during prolonged cardiopulmonary resuscitation have limited effects on myocardial blood flow: a randomized porcine studyHenrik Wagner, Michael Götberg, Bjarne Madsen Hardig, et al.
Clinical and Translational Medicine|August 15, 2015
Semi-automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studiesJohan Malm, Henrik Lindberg, David Erlinge, et al.
Pageof 49